Postbiotics and Parkinson’s Disease: What Human Evidence Exists in September 2026?
Learn how postbiotics differ from probiotics—and why Parkinson’s constipation trials do not prove they work.
How to Verify Diet and Nutrition for Parkinson’s Disease Claims in 2026: NIH, FDA, and trial records, Evidence, and Red Flags
Most diet claims for Parkinson’s lack clinical trial evidence; here’s how to identify false marketing and find evidence-based guidance.
Daily Living for Parkinson’s Disease 2026 Guide: safety, access, and evidence limits; Key Facts and Questions to Ask
Learn how to prioritize fall prevention, therapy, swallowing, driving, coverage, and the limits of available evidence.
Financial and Legal Help for Parkinson’s Disease August 2026 Update: What Changed, Why It Matters, and What to Watch Next
Check 2026 disability, Medicare, drug-cost, and Medicaid changes that could affect a household managing Parkinson’s.
What Is New With Caregiver Support for Parkinson’s Disease in August 2026? Latest NIH, FDA, and trial records and Key Takeaways
See which August 2026 Parkinson’s caregiver updates affect families now—and which remain plans, tools, or research.
Parkinson’s Disease August 2026 Update: What Changed, Why It Matters, and What to Watch Next
See which August Parkinson’s findings may affect care, which remain experimental, and what evidence needs to come next.
Diet and Nutrition for Parkinson’s Disease FAQ for August 2026: Source-Checked Answers to Common Questions
Source-checked guidance helps readers plan meals around levodopa, constipation, swallowing safety, and weight changes.
How to Read a Parkinson’s Breakthrough Headline
Most Parkinson’s “breakthrough” headlines describe a result in mice, a trial of forty people, or a company press release. None of those are worthless, but none of them mean a treatment is coming. Four checks, none of which need a science degree, separate a genuine finding from a story about one. 1. Was it in … Read more
Dopamine Agonists for Parkinson’s: Benefits, Risks, and Who They Suit
Dopamine agonists imitate dopamine at the receptor instead of replacing it. Levodopa is converted into dopamine by the neurons you still have; a dopamine agonist skips that step and stimulates the receptor directly. That single difference explains most of what follows — why they keep working when levodopa’s effect starts to fluctuate, and why their … Read more
Impulse Control Problems on Parkinson’s Medication: What Families Should Watch For
Gambling, compulsive shopping, binge eating and hypersexuality are recognised effects of Parkinson’s medication — not a change in someone’s character. They are grouped as impulse control disorders, they are strongly linked to dopamine agonists, and the person experiencing them very often does not raise it. In most families, somebody else notices first. What it actually … Read more